Recurrence of atrial fibrillation after switching from brand to generic atenolol

Gallelli, Luca; Maida, Francesca; Staltari, Orietta; Rende, Pierandrea; Russo, Emilio; Caroleo, Benedetto

doi:10.4103/0976-500X.149146

Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 5 | Issue 1 | 2014 | pp. 158–160Open access

Recurrence of atrial fibrillation after switching from brand to generic atenolol

¹^*,
¹,
¹,
¹,
¹,
¹

¹ Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.

Correspondence: Luca Gallelli
Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Email: gallelli@unicz.it

Published:: Jan 1, 2014
Received:: Jan 23, 2014
Accepted:: Jun 28, 2014
DOI:: 10.4103/0976-500X.149146

How to cite

Gallelli, L., Maida, F., Staltari, O., Rende, P., Russo, E., & Caroleo, B. (2014). Recurrence of atrial fibrillation after switching from brand to generic atenolol. Journal of Pharmacology and Pharmacotherapeutics, 5(1), 158–160. https://doi.org/10.4103/0976-500X.149146

Abstract

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

Keywords

Subject

Article metadata

Title	Recurrence of atrial fibrillation after switching from brand to generic atenolol
Authors	Luca Gallelli; Francesca Maida; Orietta Staltari; Pierandrea Rende; Emilio Russo; Benedetto Caroleo
Affiliations	Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Corresponding author	gallelli@unicz.it
Journal	Journal of Pharmacology and Pharmacotherapeutics
Volume / Issue	Vol. 5, Issue 1 (2014)